D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BASE
2101
DELISTED
Couchbase
BASE
| $3.28M | ﹤0.01% |
208,038
+38,920
| +23% | +$645K |
|
2102
Clearfield
CLFD
$401M
| $3.28M | ﹤0.01% |
110,241
+51,781
| +89% | +$1.73M |
|
2103
Pulmonx
LUNG
$52.8M
| $3.27M | ﹤0.01% |
486,555
+93,719
| +24% | +$664K |
|
|
SEM
2104
DELISTED
Select Medical
SEM
| $3.27M | ﹤0.01% |
196,024
+146,694
| +297% | +$2.7M |
|
|
CMPOW
2105
DELISTED
CompoSecure Inc Warrant
CMPOW
| $3.27M | ﹤0.01% |
843,130
+3,600
| +0.4% | +$15.9K |
|
|
CIVI
2106
CALL
DELISTED
Civitas Resources
CIVI
| $3.27M | ﹤0.01% |
93,700
+59,800
| +176% | +$2.65M |
|
2107
Ouster
OUST
$2.11B
| $3.27M | ﹤0.01% |
363,726
-900,717
| -71% | -$8.89M |
|
2108
United Fire Group
UFCS
$1.35B
| $3.27M | ﹤0.01% |
110,856
+25,217
| +29% | +$681K |
|
|
GAP
2109
The Gap Inc
GAP
$7.3B
| $3.26M | ﹤0.01% |
158,204
+79,379
| +101% | +$1.78M |
|
|
PGAC
2110
Pantages Capital Acquisition Corp
PGAC
$118M
| $3.26M | ﹤0.01% |
+325,000
| New | +$3.24M |
|
2111
HNI Corp
HNI
$3.08B
| $3.25M | ﹤0.01% |
+73,313
| New | +$3.47M |
|
2112
American Water Works
AWK
$27B
| $3.24M | ﹤0.01% |
+21,983
| New | +$2.9M |
|
2113
Nutrien
NTR
$33.9B
| $3.24M | ﹤0.01% |
65,265
-305,448
| -82% | -$15.6M |
|
2114
BrightView Holdings
BV
$1.24B
| $3.24M | ﹤0.01% |
252,301
+7,964
| +3% | +$114K |
|
|
TBCH
2115
Turtle Beach Corp
TBCH
$238M
| $3.23M | ﹤0.01% |
226,521
-76,656
| -25% | -$1.28M |
|
2116
iShares MSCI Australia ETF
EWA
$1.38B
| $3.22M | ﹤0.01% |
137,321
+97,268
| +243% | +$2.36M |
|
2117
Compass Diversified
CODI
$752M
| $3.22M | ﹤0.01% |
172,343
+122,964
| +249% | +$2.54M |
|
2118
Accuray
ARAY
$27.5M
| $3.21M | ﹤0.01% |
1,793,391
| – | – |
|
|
DX
2119
Dynex Capital
DX
$3.17B
| $3.21M | ﹤0.01% |
+246,546
| New | +$3.3M |
|
2120
Synaptics
SYNA
$4.05B
| $3.21M | ﹤0.01% |
50,315
-146,429
| -74% | -$10.6M |
|
2121
Gold Fields
GFI
$28.8B
| $3.2M | ﹤0.01% |
+145,016
| New | +$2.65M |
|
2122
Ascendis Pharma A/S
ASND
$16.5B
| $3.2M | ﹤0.01% |
20,526
-17,454
| -46% | -$2.49M |
|
2123
CALL
The Mosaic Company
MOS
$7.19B
| $3.2M | ﹤0.01% |
118,400
+100
| +0.1% | +$2.65K |
|
2124
Eastman Chemical
EMN
$7.69B
| $3.2M | ﹤0.01% |
+36,284
| New | +$3.43M |
|
2125
ArcBest
ARCB
$3.15B
| $3.2M | ﹤0.01% |
+45,295
| New | +$3.92M |
|
Similar funds
D.E. Shaw & Co's Q1 2025 Portfolio in Review
As of Q1 2025, D.E. Shaw & Co held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- D.E. Shaw & Co's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- D.E. Shaw & Co added most to GE Vernova in Q1 2025, an estimated $686M increase.
- D.E. Shaw & Co's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- D.E. Shaw & Co opened 569 new positions and closed 704 in Q1 2025.
- D.E. Shaw & Co's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.